Jian Mei Gan

Direttore/Membro del Consiglio presso Zensun (Shanghai) Sci & Tech Co., Ltd.

64 anni

Consumer Services

Health Technology

Profilo

Jian Mei Gan is an Independent Director at Zensun (Shanghai) Sci & Tech Co., Ltd.
She has a Bachelor's degree from Fudan University, a Master's in Business Administration from The Wharton School of the University of Pennsylvania, and a graduate degree from Beijing Foreign Studies University.

Posizioni attive di Jian Mei Gan

Società	Posizione	Inizio
Zensun (Shanghai) Sci & Tech Co., Ltd. Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China.	Direttore/Membro del Consiglio	22/01/2019

Tutte le posizioni attive di Jian Mei Gan

Formazione di Jian Mei Gan

Fudan University	Undergraduate Degree
Beijing Foreign Studies University	Graduate Degree
The Wharton School of the University of Pennsylvania	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jian Mei Gan

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Zensun (Shanghai) Sci & Tech Co., Ltd. Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China.	Health Technology